Posts
- Category: hdbuzz (continued)
- Liftoff: First humans treated with gene silencing drugs for HD!
- Lighting the way: A new biomarker for Huntington’s disease
- Lithium with a twist gets second chance for HD
- Looking Past the Spin: Results from a Clinical Trial of Cysteamine
- Mapping the anatomy of HD: a whole-brain history
- Mapping the neighborhood: huntingtin's new protein partners
- Measuring harmful huntingtin protein in the brain’s bath water
- Melatonin alterations in Huntington's disease help explain trouble with sleep
- More evidence points to Huntington's disease exercise benefit
- mTORC1 tips the scales in Huntington’s disease mice
- New collaboration seeks to speed Huntington's disease drug licensing
- New interest in an old target
- New results bring BDNF therapies into focus
- New roles for huntingtin: removing a healthy protein to understand its function
- New study reveals a potential HD biomarker
- New tool to measure outcomes in Huntington’s Disease clinical trials
- Novel research technique suggests an antioxidant gene protects vulnerable neurons
- NUB1: enhancing clearance to decrease mutant huntingtin
- Nuova sperimentazione del PBT2 prodotto dalla Prana Biotech per la malattia di Huntington: notizie importanti
- Of mice and men: using animal models to study Huntington's disease
- Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms
- Phosphodiesterase inhibitors: new HD drugs entering trials soon
- Planting trees together: The 2016 Huntington's Disease Society of America Convention
- Positive results announced for re-worked tetrabenazine drug in Huntington's disease
- Prana announces results of Reach2HD trial of PBT2 for Huntington's disease
- Prana Biotech publishes Huntington's disease animal model data for PBT2
- Precision huntingtin-lowering drug trials target the mutant protein
- Prominent Huntington's disease researcher "fabricated data" in grant applications
- Proposed Huntington's disease 'biomarker' is not useful, new study suggests
- Quanto lungo é troppo lungo? Ripensando alla 'zona grigia' della malattia di Huntington
- Raptor announces results of cysteamine trial for Huntington's disease
- Roche announces details of its 'pivotal' huntingtin-lowering study
- Sarà una nuova tecnica a rivoluzionare il test genetico per la Malattia di Huntington?
- Sheep leading the flock: metabolism and biomarkers in HD
- Shooting the messenger with single-stranded RNA gene silencing
- Should we worry about a huntingtin invasion?
- Sleep, cilia and HD
- Sorry folks, the PRIDE-HD trial did NOT show that Pridopidine slows the progression of Huntington's disease
- Splicing with danger: a new way of thinking about the harmful Huntington's disease protein
- Success! ASO drug reduces levels of mutant protein in Huntington's disease patients
- Switch off the genome editor when you’re done
- Taking new targets to the bank: the DNA repair protein ‘ATM’ is overactive in Huntington's disease
- Targeting oxidative stress in Huntington's Disease
- The 'N17' region of huntingtin protein: an address label in Huntington's disease?
- The 2013 HDBuzz Prize for Young Science Writers
- The benefits of migration, highlighted in Huntington's disease
- The brain in Huntington's disease: greater than the sum of its parts?
- The structure of the protein that causes Huntington's disease, revealed
- The sweet lowdown: Huntington's disease brains use sugar differently
- The University of New Orleans has NOT discovered a cure for Huntington's disease
Plugin by dagondesign.com
